Interview highlights 

0:15 – Why Stephen returned to pharma and what he learned from outside

1:04 – How the ABPI can support the industry through a period of change

2:04 – Influence of the ABPI beyond the UK on the broader global scene

2:56 – Stephen’s vision for the future of pharma

4:15 – Addressing the reputational issues faced by pharma

5:34 – Key game changers for pharma and impact on the ABPI

6:38 – Digital communications

8:39 – How the UK can remain a key global centre for pharma

10:09 – Stephen’s ambition for the ABPI by the end of his tenure